-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Neutral on Amphastar Pharma, Lowers Price Target to $21

Benzinga·05/11/2026 18:02:52
Listen to the news
Piper Sandler analyst David Amsellem reiterates Amphastar Pharma (NASDAQ:AMPH) with a Neutral and lowers the price target from $25 to $21.